Transcriptional repression of catalase in mouse skin tumor progression

Neoplasia

Volumn 6, Issue 5, 2004, Pages 440-448

  Kwei, Kevin A ^a   Finch, Joanne S ^a   Thompson, Eric J ^a   Bowden, G Tim ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Antioxidant; Catalase; Transcriptional regulation; Tumor progression and mouse skin carcinogenesis; Wilm's tumor suppressor 1

Indexed keywords

CATALASE; LUCIFERASE; MESSENGER RNA; WT1 PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CANCER CELL; CANCER CELL CULTURE; CARCINOMA; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ASSAY; ENZYME REPRESSION; FEMALE; GENE CONTROL; MOUSE; NEPHROBLASTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; SKIN TUMOR; TUMOR GROWTH;

EID: 6944241318     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04127     Document Type: Article

References (34)

1. Jemal A, Thomas A, Murray T, and Thun M (2002). Cancer statistics. CA Cancer J Clin 52, 23-47.
2. Stratton SP (2001). Prevention of non-melanoma skin cancer. Curr Oncol Rep 3, 295-300.
3. Boutwell RK (1974). The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol 2, 419-443.
4. Balmain A, Ramsden M, Bowden GT, and Smith J (1984). Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 307, 658-660.
5. Gupta A, Rosenberger SF, and Bowden GT (1999). Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines. Carcinogenesis 20, 2063-2073.
6. Strickland JE, Greenhalgh DA, Koceva-Chyla A, Hennings H, Restrepo C, Balaschak M, and Yuspa SH (1988). Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res 48, 165-169.
7. Gupta A, Butts B, Kwei KA, Dvorakova K, Stratton SP, Briehl MM, and Bowden GT (2001). Attenuation of catalase activity in the malignant phenotype plays a functional role in an in vitro model for tumor progression. Cancer Lett 173, 115-125.
8. Butts BD, Kwei KA, Bowden GT, and Briehl MM (2003). Elevated basal reactive oxygen species and phospho-Akt in murine keratinocytes resistant to ultraviolet B-induced apoptosis. Mol Carcinog 37, 149-157.
9. Futscher BW, Pieper RO, Dalton WS, and Erickson LC (1992). Genespecific DNA interstrand cross-links produced by nitrogen mustard in the human tumor cell-line Colo320HSR. Cell Growth Differ 3, 217-223.
10. Patrone G, Puppo F, Ceccherine I, Puliti A, and Ravazzolo R (2000). Nuclear run-on assay using biotin labeling, magnetic bead capture and analysis by fluorescence-based RT-PCR. BioTechniques 29, 1012-1017.
11. Clark SJ, Harrison J, Paul CL, and Frommer M (1994). High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22, 2990-2997.
12. Luo D and Rando TA (2003). The regulation of catalase gene expression in mouse muscle cells is dependent on the CCAAT-binding factor NF-Y. Biochem Biophys Res Commun 303, 609-618.
13. Nelson KG and Slaga TJ (1982). Keratin modifications in epidermis, papillomas, and carcinomas during two-stage carcinogenesis in the SENCAR mouse. Cancer Res 42, 4176-4181.
14. Rohrdanz E and Kahl R (1998). Alterations of antioxidant enzyme expression in response to hydrogen peroxide. Free Radic Biol Med 24, 27-38.
15. Sampath D and Perez-Polo R (1997). Regulation of antioxidant enzyme expression by NGF. Neurochem Res 22, 351-362.
16. Nenoi M, Ichimura S, Mita K, Yukawa O, and Cartwright IL (2001). Regulation of the catalase gene promoter by Sp1, CCAAT-recognizing factors, and a WT1/Egr-related factor in hydrogen peroxide-resistant HP100 cells. Cancer Res 61, 5885-5894.
17. Sato K, Ito K, Kohara H, Yamaguchi Y, Adachi K, and Endo H (1992). Negative regulation of catalase gene expression in hepatoma cells. Mol Cell Biol 12, 2525-2533.
18. Reimer DL, Bailley J, and Singh SM (1994). Complete cDNA and 5′ genomic sequences and multilevel regulation of the mouse catalase gene. Genomics 21, 325-336.
19. Greger V, Debus N, Lohmann D, Hopping W, Passarge E, and Horsthemke B (1994). Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum Genet 94, 491-496.
20. Herman JG, Jen J, Merlo A, and Baylin SB (1996). Hypermethylation- associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res 56, 722-727.
21. Sun Y, Colburn NH, and Oberley LW (1993). Depression of catalase gene expression after immortalization and transformation of mouse liver cells. Carcinogenesis 14, 1505-1510.
22. el-Hage S and Singh SM (1989). Regulation of catalase-specific mRNA and its processing during development in mice. Dev Genet 10, 339-344.
23. Kim HS, Lee TB, and Choi CH (2001). Down-regulation of catalase gene expression in the doxorubicin-resistant AML subline AML-2/DX100. Biochem Biophys Res Commun 281, 109-114.
24. Yamaguchi Y, Sato K, and Endo H (1992). Depression of catalase gene expression in the liver of tumor bearing nude mice. Biochem Biophys Res Commun 189, 1084-1089.
25. Akman SA, Forrest G, Chu FF, and Doroshow JH (1989). Resistance to hydrogen peroxide associated with altered catalase mRNA stability in MCF7 breast cancer cells. Biochim Biophys Acta 930, 140-144.
26. Clerch LB, Iqbal J, and Massaro D (1991). Perinatal rat lung catalase gene expression: influence of corticosteroid and hyperoxia. Am J Physiol 260, L428-433.
27. Reimer DL and Singh SM (1996). Distinct mRNA-binding protein interacting with short repeat sequences of the 3′ UTR may be involved in the post-transcriptional regulation of the mouse catalase gene Cas-1. DNA Cell Biol 15, 317-328.
28. Shaffer JB and Preston KE (1990). Molecular analysis of an acatalasemic mouse mutant. Biochem Biophys Res Commun 173, 1043-1050.
29. Georgel PT, Horowitz-Scherer RA, Adkins N, Woodcock CL, Wade PA, and Hansen JC (2003). Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J Biol Chem 278, 32181-32188.
30. Takeuchi T, Nakamura S, Kayasuga A, Isa S, and Sato K (2000). Multiple elements for negative regulation of the rat catalase gene expression in dedifferentiated hepatoma cells. J Biochem (Tokyo) 128, 1025-1031.
31. Van Remmen H, Williams MD, Yang H, Walter CA, and Richardson A (1998). Analysis of the transcriptional activity of the 5′-flanking region of the rat catalase gene in transiently transfected cells and in transgenic mice. J Cell Physiol 174, 18-26.
32. Nakashima H, Yamamoto M, Goto K, Osumi T, Hashimoto T, and Endo H (1989). Isolation and characterization of the rat catalase-encoding gene. Gene 79, 279-288.
33. Quan F, Korneluk RG, Tropak MB, and Gravel RA (1986). Isolation and characterization of the human catalase gene. Nucleic Acids Res 14, 5321-5335.
34. Zhao Y, Xue Y, Oberley TD, Kiningham KK, Lin SM, Yen HC, Majima H, Hines J, and St Clair D (2001). Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res 61, 6082-6088.